LSV Asset Management Decreases Position in HCA Healthcare, Inc. $HCA

LSV Asset Management lessened its holdings in HCA Healthcare, Inc. (NYSE:HCA) by 2.1% during the fourth quarter, Holdings Channel.com reports. The firm owned 825,867 shares of the company’s stock after selling 17,756 shares during the quarter. HCA Healthcare accounts for 0.8% of LSV Asset Management’s investment portfolio, making the stock its 24th largest holding. LSV Asset Management’s holdings in HCA Healthcare were worth $385,564,000 as of its most recent SEC filing.

A number of other large investors also recently added to or reduced their stakes in HCA. Advisory Alpha LLC increased its position in shares of HCA Healthcare by 12.4% in the fourth quarter. Advisory Alpha LLC now owns 2,881 shares of the company’s stock valued at $1,345,000 after acquiring an additional 318 shares during the period. Markel Group Inc. increased its position in shares of HCA Healthcare by 7.3% in the fourth quarter. Markel Group Inc. now owns 80,680 shares of the company’s stock valued at $37,666,000 after acquiring an additional 5,467 shares during the period. Global Retirement Partners LLC increased its position in shares of HCA Healthcare by 135.4% in the fourth quarter. Global Retirement Partners LLC now owns 2,568 shares of the company’s stock valued at $1,199,000 after acquiring an additional 1,477 shares during the period. Aspen Investment Management Inc increased its position in shares of HCA Healthcare by 7.2% in the fourth quarter. Aspen Investment Management Inc now owns 749 shares of the company’s stock valued at $350,000 after acquiring an additional 50 shares during the period. Finally, MJP Associates Inc. ADV increased its position in shares of HCA Healthcare by 2.9% in the fourth quarter. MJP Associates Inc. ADV now owns 749 shares of the company’s stock valued at $350,000 after acquiring an additional 21 shares during the period. Hedge funds and other institutional investors own 62.73% of the company’s stock.

Wall Street Analyst Weigh In

A number of research firms have issued reports on HCA. Mizuho boosted their price objective on shares of HCA Healthcare from $540.00 to $585.00 and gave the company an “outperform” rating in a research report on Wednesday, February 25th. KeyCorp reduced their price target on shares of HCA Healthcare from $550.00 to $510.00 and set an “overweight” rating on the stock in a research report on Monday, April 27th. Wells Fargo & Company reduced their price target on shares of HCA Healthcare from $481.00 to $436.00 and set an “equal weight” rating on the stock in a research report on Monday, April 27th. Sanford C. Bernstein reduced their price target on shares of HCA Healthcare from $541.00 to $503.00 and set a “market perform” rating on the stock in a research report on Tuesday, April 28th. Finally, Cantor Fitzgerald reiterated an “overweight” rating on shares of HCA Healthcare in a research report on Wednesday, March 4th. Sixteen investment analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has given a Sell rating to the company. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $515.77.

HCA Healthcare Stock Performance

Shares of HCA opened at $394.40 on Friday. The stock has a market cap of $87.49 billion, a PE ratio of 13.56, a price-to-earnings-growth ratio of 1.24 and a beta of 1.18. HCA Healthcare, Inc. has a fifty-two week low of $330.00 and a fifty-two week high of $556.52. The firm’s 50-day simple moving average is $465.16 and its two-hundred day simple moving average is $483.61.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings data on Friday, April 24th. The company reported $7.15 earnings per share for the quarter, missing analysts’ consensus estimates of $7.19 by ($0.04). The business had revenue of $19.11 billion during the quarter, compared to analysts’ expectations of $19.09 billion. HCA Healthcare had a negative return on equity of 295.93% and a net margin of 8.89%.HCA Healthcare’s revenue for the quarter was up 4.3% compared to the same quarter last year. During the same quarter last year, the company posted $6.45 EPS. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. Equities research analysts predict that HCA Healthcare, Inc. will post 30.07 EPS for the current year.

HCA Healthcare Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 30th. Shareholders of record on Tuesday, June 16th will be issued a $0.78 dividend. This represents a $3.12 dividend on an annualized basis and a yield of 0.8%. The ex-dividend date is Tuesday, June 16th. HCA Healthcare’s dividend payout ratio is 10.73%.

HCA Healthcare Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.